Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

PURPOSE: Sensitivity to a tyrosine kinase inhibitor (TKI) is correlated with the presence of somatic mutations that affect the kinase domain of epidermal growth factor receptor (EGFR). Development of resistance to TKI is a major therapeutic problem in non-small cell lung cancer (NSCLC). Aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudo, Makoto, Chin, Tan Min, Mori, Seiichi, Doan, Ngan B., Said, Jonathan W., Akashi, Makoto, Koeffler, H. Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636434/
https://www.ncbi.nlm.nih.gov/pubmed/23515752
http://dx.doi.org/10.1007/s00280-013-2132-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636434/
https://www.ncbi.nlm.nih.gov/pubmed/23515752
http://dx.doi.org/10.1007/s00280-013-2132-y

Ejemplares similares